Adma Biologics Inc. (NASDAQ:ADMA): Dennis Purcell’s Aisling Capital II LP filed an amended 13D.
You can check out Aisling Capital’s latest holdings and filings here.
Please follow Aisling Capital (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Aisling Capital or update its stock holdings.
Follow Dennis Purcell's Aisling Capital
You can access the original SEC filing by clicking here.
Ownership Summary Table
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Aisling Capital II | 3,608,171 | 0 | 3,608,171 | 0 | 3,608,171 | 8.0% |
Aisling Capital Partners | 3,608,171 | 0 | 3,608,171 | 0 | 3,608,171 | 8.0% |
Aisling Capital Partners | 3,608,171 | 0 | 3,608,171 | 0 | 3,608,171 | 8.0% |
Steve Elms | 0 | 3,608,171 | 0 | 3,608,171 | 3,608,171 | 8.0% |
Dennis Purcell | 0 | 3,608,171 | 0 | 3,608,171 | 3,608,171 | 8.0% |
Andrew Schiff | 0 | 3,608,171 | 0 | 3,608,171 | 3,608,171 | 8.0% |